Sanofi-Aventis Investigational Site Number 840119 — Birmingham, Alabama

Sanofi-Aventis Investigational Site Number 840119 is a clinical research site located in Birmingham, Alabama, United States 35203.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Sanofi-Aventis Investigational Site Number 840119 has participated in 5 clinical trials.

Therapeutic areas: Colorectal Neoplasms, Neoplasm Metastasis, Diabetes Mellitus Type 2.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

• University of Alabama Birmingham - Main & Highlands
• University of Alabama Birmingham Lung Health Center
• University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic
• The University Of Alabama Of Birmingham
• University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility
• University of Alabama at Birmingham - School of Medicine-Cardiology ( Site 0153)
• University of Alabama Hospitals
• UAB Hospital /ID# 262565
• University of Alabama at Birmingham Women & Infants Center
• University of Alabama at Birmingham (UAB) - Center for Education & Research on Therapeutics of Musculoskeletal Disorders
• University of Alabama at Birmingham Endocrinology Department
• University of Alabama-The Kirklin Clinic

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sanofi-Aventis Investigational Site Number 840119?

Sanofi-Aventis Investigational Site Number 840119 has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sanofi-Aventis Investigational Site Number 840119 conducted?

Sanofi-Aventis Investigational Site Number 840119 has 5 clinical trials on record. Their work covers Colorectal Neoplasms, Neoplasm Metastasis, Diabetes Mellitus Type 2.

Is Sanofi-Aventis Investigational Site Number 840119 accredited by Crixeo Clinical Trials?

Sanofi-Aventis Investigational Site Number 840119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sanofi-Aventis Investigational Site Number 840119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.